CXCL13, in turn, potentiates the interaction between ILC3 and stromal cells, resulting in the increased production of RANKL on stromal cells, which promotes tumor cell migration and lymph node metastasis by the RANK-RANKL pathway [131]. The gene discussed is CXCL13; the disease is neoplasm.